Arkolith/Insider Trading/CVKD/Form 4/A

Pham Quang X

CEO and Chairman, Director, 10% OwnerCadrenal Therapeutics, Inc. (CVKD) · full profile →Form 4/A · filed Mar 24, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 23, 2025Grant(A)65K—$065K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001013762-25-001779) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML